OSMYX | RISAX | OSMYX / RISAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 12 years | - |
Gain YTD | 6.257 | 3.643 | 172% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.59B | 389M | 923% |
Annual Yield % from dividends | 1.08 | 0.97 | 111% |
Returns for 1 year | -8.07 | 1.35 | -599% |
Returns for 3 years | -15.04 | -8.75 | 172% |
Returns for 5 years | -13.90 | 6.07 | -229% |
Returns for 10 years | 19.08 | 56.55 | 34% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSIQX | 10.83 | -0.06 | -0.55% |
Morgan Stanley Inst International Eq I | |||
NQCRX | 5.11 | -0.08 | -1.54% |
Nuveen Large Cap Value Opportunities I | |||
SDLAX | 18.71 | -0.38 | -1.99% |
SEI Dynamic Asset Allocation A (SIIT) | |||
TNRAX | 18.71 | -0.41 | -2.13% |
1290 Avantis U.S. Large Cap Growth A | |||
FTHCX | 84.40 | -2.38 | -2.74% |
Fidelity Advisor Technology C |